TRAW

NASDAQStock

Traws Pharma, Inc.

$2.01+0.04 (+1.98%)

52-Week Range

$1.09

$3.13

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.76

Volume

298.1K

Avg Volume

84.9K

Performance

+5.21%

-9.82%

-2.42%

YTD

+51.88%

-26.28%

-90.57%

Price Chart

ETF Exposure

TRAW is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	17	$0	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	642	$0	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	3	$0	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	365,661	$146	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	1,923	$1	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	165	$0	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	321,970	$128	$84.10B	0.05%

About TRAW ETF Exposure

Traws Pharma, Inc. (TRAW) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $2.01. Investors can gain exposure to TRAW through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TRAW, sorted by portfolio weight.